Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from ramses study
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/895/%c3%87akal-Beytullah%282017%29.pdf.jpg?sequence=5&isAllowed=y)
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2017Yazar
Başaran, ÖzcanDoğan, Volkan
Biteker, Murat
Karadeniz Özpamuk, Fatma
Tekkesin, Ahmet İlker
Çakıllı, Yasin
Türkkan, Ceyhan
Hamidi, Mehmet
Demir, Vahit
Gürsoy, Mustafa Ozan
Öztürk, Müjgan Tek
Aksan, Gökhan
Seyis, Sabri
Ballı, Mehmet
Alıcı, Mehmet Hayri
Bozyel, Serdar
Kırma, Cevat
Beton, Osman
Tekinalp, Mehmet
Aykan, Ahmet Çağrı
Kalaycıoğlu, Ezgi
Bolat, İsmail
Taşar, Onur
Şafak, Özgen
Kalçık, Macit
Yaman, Mehmet
İnci, Sinan
Altıntaş, Bernas
Kalkan Semih
Çalık, Feyza
Karaca, Oğuz
Helvacı, Füsun
Akay Halli, Kadriye
Çanga, Yiğit
Çelebi, Savaş
Altuntaş, Emine
Aytürk, Mehmet
Güneş, Hacı Murat
Bezgin, Tahir
Aksakal, Aytekin
Çakal, Beytullah
Çolak, Ayşe
Kaplan, Özgür
Tatlısu, Adem
Gözübüyük, Gökhan
Demirelli, Selami
Kaya, Adnan
Rencüzoğulları, İbrahim
Bayram, Zübeyde
Şimşek, Ziya
Civan, Murat
Batgharel, Ulaankhu
Ata, Ali Ekber
Göl, Gökhan
Mert Gurbet Özge
Mert, Kadir Uğur
Değirmencioğlu, Aleks
Candan, Özkan
Çelebi Özcan, Özlem
Doğan, Cem
Yavuz, Fethi
Ulucan, Şeref
Arısoy, Arif
Şahin Dilekçi, Bingül
Ermiş, Emrah
Gökaslan, Serkan
Pektaş, İdris
Tanındı, Aslı
Tekin, Kamuran
Sancar Memiç, Kadriye
Çekiç, Edip Güvenç
Başaran, Filiz Nesrin
Altun, İbrahim
Üst veri
Tüm öğe kaydını gösterKünye
Başaran Ö., Dogan V., Biteker M., Karadeniz F.Ö., Tekkesin A., Çakıllı Y. ... Altun I. (2017). Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from ramses study. European Journal of Internal Medicine, 40, 50-55. https://dx.doi.org/10.1016/j.ejim.2017.02.011Özet
Objective No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate possible differences between secondary (SH) and tertiary hospital (TH) settings in the effectiveness of implementing AF treatment strategies. Methods Baseline characteristics of 6273 patients with non-valvular AF enrolled in the RAMSES (ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies in Turkey) study were compared. Results Of the study population, 3312 (52.8%) patients were treated in THs and 2961 (47.2%) patients were treated in SHs. Patients treated in the SH setting were older (70.8 ± 9.8 vs. 68.7 ± 11.4 years, p < 0.001), had a lower socioeconomic status, had a higher CHA2DS2VASc and HASBLED scores (3.4 ± 1.4 vs. 3.1 ± 1.7, p < 0.001 and 1.7 ± 1.0 vs. 1.6 ± 1.1, p < 0.001 respectively), and had more comorbidities than patients treated in THs. Inappropriate oral anticoagulant use was more prevalent in SHs than THs (31.4% vs. 25.6%, p < 0.001). When over- and undertreatment rates were compared among hospital types, overtreatment was more prevalent in THs (7.6% vs. 0.9%, p < 0.001) while undertreatment was more common in SHs (30.5% vs. 17.9%, p < 0.001). Conclusion This study demonstrates the marked disparity between patient groups with AF presenting at SHs and THs. The use of guideline-recommended therapy is not adequate in either type of centre, overtreatment was more prevalent in THs and undertreatment was more prevalent in SHs.
WoS Q Kategorisi
Q1Scopus Q Kategorisi
Q2Kaynak
European Journal of Internal MedicineCilt
40Koleksiyonlar
- Makale Koleksiyonu [3790]
- PubMed İndeksli Yayınlar Koleksiyonu [4251]
- Scopus İndeksli Yayınlar Koleksiyonu [6601]
- WoS İndeksli Yayınlar Koleksiyonu [6677]
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
Başaran, Özcan; Doğan, Volkan; Beton, Osman; Tekinalp, Mehmet; Aykan, Ahmet Cağrı; Kalaycıoğlu, Ezgi; Bolat, İsmail; Taşar, Onur; Şafak, Özgen; Kalcık, Macit; Yaman, Mehmet; İnci, Sinan; Altıntaş, Bernas; Kalkan, Sedat; Kırma, Cevat; Biteker, Murat; Karadeniz Özpamuk, Fatma; Tekkesin, Ahmet İlker; Çakıllı, Yasin; Türkkan, Ceyhan; Hamidi, Mehmet; Demir, Vahit; Gürsoy, Mustafa Ozan; Öztürk Tek, Müjgan; Aksan, Gökhan; Seyis, Sabri; Ballı, Mehmet; Alıcı, Mehmet Hayri; Bozyel, Serdar; Altun, İbrahim; Çalık, Feyza; Karaca, Oğuz; Helvacı, Füsun; Akay, Kadriye; Canga, Yiğit; Çelebi, Savaş; Altuntaş, Emine; Aytürk, Mehmet; Güneş, Hacı Murat; Bezgin, Tahir; Aksakal, Aytekin; Çakal, Beytullah; Çolak, Ayşe; Kaplan, Özgür; Tatlısu, Adem; Gözübüyük, Gökhan; Demirelli, Selami; Kaya, Adnan; Rencuzoğullari, İbrahim; Bayram, Zübeyde; Şimsek, Zeki; Civan, Murat; Batgharel, Ulaankhu; Ata, Ali Ekber; Göl, Gökhan; Mert, Gurbet Özge; Mert, Kadir Uğur; Değirmencioğlu, Aleks; Candan, Özkan; Çelebi, Özlem Özcan; Doğan, Cem; Yavuz, Fethi; Ulucan, Şeref; Arısoy, Arif; Şahin, Bingül Dilekçi; Ermiş, Emrah; Gökaslan, Serkan; Pektaş, İdris; Tanındı, Aslı; Tekin, Kamuran; Sancar Memiç, Kadriye; Çekic, Edip Güvenç; Başaran, Nesrin Filiz (Lippincott Williams & Wilkins, 2016)This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ... -
Nivolumab for relapsed or refractory Hodgkin lymphoma: Real-life experience
Beköz, Hüseyin Saffet; Karadurmuş, Nuri; Paydaş, Semra; Türker, Alev; Toptaş, Tayfur; Fıratlı Tuğlular, Tülin; Sönmez, Mehmet Giray; Gülbaş, Zafer; Tekgündüz, Emre; Kaya, Ali Hakan; Özbalak, Murat; Taştemir, N; Kaynar, Leylagül; Yildirim Rahşan; Karadoğan, İhsan; Arat Ersöz, Mutlu; Pepedil Tanrıkulu, Funda; Özkocaman, Vildan; Abali, Hüseyin; Turgut, Mehmet; Kurt Yüksel, M; Özcan, Muhit; Doğu, Mehmet Hilmi; Kabukçu Hacıoğlu, Sibel; Barişta, İbrahim; Demirkaya, Metin; Köseoğlu, Fatoş Dilan; Toprak, Selami Koçak; Yilmaz, Mehmet Birhan; Demirkürek, Hüseyin; Demirkol, Mehmet Onur; Ferhanoğlu, Burhan (Oxford University Press, 2017)Background: Reed-Sternberg cells of classical Hodgkin's lymphoma (cHL) are characterized by genetic alterations at the 9p24.1 locus, leading to over-expression of programmed death-ligand 1 and 2. In a phase 1b study, ... -
Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey
Gök, Gülay; Zoghi, Mehdi; Sinan, Ümit Yaşar; Kılıç, Salih; Tokgözoğlu, Lale; Sümerkan, Mutlu Çağan; Emren, Volkan; Bekar, Lütfü; Cerşit, Sinan; Tunç, Elif; Ulucan, Şeref; Altuntaş, Emine; Canpolat, Uğur; Özmen, Namık; Açıksarı, Gönül; Doğan, Nazile Bilgin; Günay, Şeyda; Kemaloğlu, Meltem Didem; Nacar, Alper Buğra; Karakoyun, Süleyman; İnci, Sinan; Özlek, Bülent; Aslan, Onur; Baykız, Derya; Gündüz, Sabahattin; Köroğlu, Sedat; Helvacı, Ayşen; Coşkun, Raşit; Yüksel, İsa Öner; Çetin, Şükrü; Yesin, Mahmut; Gürsoy, Mustafa Ozan; Çatırlı Enar, Sibel; Tek Öztürk, Müjgan; Yılmaz, Aykut; Başaran, Özcan; Okyay, Kaan; Öztürk, Cengiz; Çelik, Oğuzhan; Yalçınkaya, Emre; Aslan, Vedat; Şenol, Utku; Uçar, Fatih Mehmet; Kozluca, Volkan; Türkoğlu, Ebru İpek; Şekuri, Cevat; Ertürk, Mehmet; Altun, İbrahim; Belen, Erdal; Aksan, Gökhan; Yıldırım, Erkan; Sayın, Ahmet; Akkoyun, Dursun Çayan; Tunçez, Abdullah; Doğan, Volkan; Gürel, Yusuf Emre; Demirelli, Selami; Koca, Çiğdem; Biteker, Murat; Bas, Hasan Aydın; Güzet, Feza; Taçoy, Gülten; Alpsoy, Şeref; Turan, Turhan; Davutoğlu, Vedat; Birdane, Alparslan; Onrat, Ersel; Baha, Mehmet Reşat; Yılmaz, Sabiye; Altay, Servet; Alıcı, Mehmet Hayri; Özcan, İsmail Türkay; Kuş, Görkem; Demir, Gültekin Günhan; Sancar, Kadriye Memiç; Demirçelik, Muhammed Bora; Yanık, Ahmet; Akciğer, Atike Nazlı; Hoşcan, Yeşim; Arslan, Kürşat; Otlu, Yılmaz Ömür; Şahin, İsmail; Ersoy, İbrahim; YIlmaz, Dilek Çiçek; Mert, Kadir Uğur; Varim, Perihan; Arı, Hatem (Turkish Society of Cardiology, 2019)Objective: Heart failure (HF) has a high prevalence and mortality rate in elderly patients; however, there are few studies that have focused on patients older than 80 years. The aim of this study is to describe and compare ...